Log In
Print
BCIQ
Print
Print this Print this
 

Nuedexta, dextromethorphan/quinidine (AVP-923) (formerly Neurodex)

Also known as: formerly Zenvia

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionCombination of the NMDA receptor antagonist dextromethorphan with quinidine sulfate, a cytochrome P450 2D6 enzyme inhibitor
Molecular Target NMDA receptor ; Sigma-1 receptor
Mechanism of ActionCytochrome P450 inhibitor; NMDA receptor antagonist
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$3,500.0M

$3,500.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today